From migraines to metabolic syndrome, speakers at Benefits Canada’s Calgary Drug Trends Summit provided plan sponsors with solutions to the many challenges they face around their drug plans and the well-being of their workforce. And as employers continue to grapple with rising costs, the sessions addressed the various options available to help them keep their drug plans sustainable.
A large crowd gathered at the Fairmont Palliser hotel on Nov. 23 to hear five presenters speak about the big issues employers face. Below are some of the highlights of the sessions from the event.
Don’t forget to check out photos from the event in our photo gallery.
Metabolic syndrome targeted as part of efforts to reduce chronic disease drug spending
Despite rising health-care costs, there’s a gap when it comes to seeing the results of all of that spending, according to a speaker at the recent Calgary Drug Trends Summit.
Read more
Migraines an underestimated, disabling and treatable condition, says medical expert
A migraine is more than just a headache.
Read more
Solutions to ease employee backlash to plan design changes
Keeping private drug plans sustainable is key for all Canadians. While measures such as mandatory generic substitution and prior authorization are standard solutions in many employer drug plans, costs continue to rise.
Read more
‘The sky is not falling’ on drug costs
While Canadians hear about the high cost of drugs all of the time, “the sky is not falling,” said Jim Favaro, senior manager for private payers at Amgen Canada Inc.
Read more
Leadership, expansive programs key to University of Calgary’s mental-health strategy
What can each person do to create a community of caring where people feel connected, supported and cared for?
Read more